IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; lactose monohydrate; iron oxide red; titanium dioxide; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; macrogol 6000; hyprolose; magnesium stearate; colloidal anhydrous silica - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVAPRO HCT 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

avapro hct 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: carnauba wax; lactose monohydrate; magnesium stearate; hypromellose; croscarmellose sodium; silicon dioxide; microcrystalline cellulose; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

KARVEZIDE 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

karvezide 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; magnesium stearate; silicon dioxide; microcrystalline cellulose; hypromellose; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN HCTZ ARROW 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan hctz arrow 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose monohydrate; pregelatinised maize starch; poloxamer; croscarmellose sodium; microcrystalline cellulose; povidone; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Irbesartan HCTZ Fair-Med 150mg/12.5mg film-coated Tablets Malta - English - Medicines Authority

irbesartan hctz fair-med 150mg/12.5mg film-coated tablets

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - hydrochlorothiazide, irbesartan - film-coated tablet - hydrochlorothiazide 12.5 mg irbesartan 150 mg - agents acting on the renin-angiotensin system

STADA IRBESARTAN HCT 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 150/12.5 irbesartan/hydrochlorothiazide 150 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; povidone; microcrystalline cellulose; magnesium stearate; hydrogenated castor oil; maize starch; lactose monohydrate - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

STADA IRBESARTAN HCT 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister Australia - English - Department of Health (Therapeutic Goods Administration)

stada irbesartan hct 300/12.5 irbesartan/hydrochlorothiazide 300 mg/12.5 mg tablet blister

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; povidone; hydrogenated castor oil; maize starch; magnesium stearate; lactose monohydrate; croscarmellose sodium - stada irbesartan hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Irbesartan/ Hydrochlorothiazide Aurobindo 150mg/12.5mg film-coated Tablets Malta - English - Medicines Authority

irbesartan/ hydrochlorothiazide aurobindo 150mg/12.5mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, irbesartan - film-coated tablet - hydrochlorothiazide 12.5 mg irbesartan 150 mg - agents acting on the renin-angiotensin system

Irbesartan 300mg Hydrochlorothiazide 12.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

irbesartan 300mg hydrochlorothiazide 12.5mg tablets

lupin healthcare (uk - irbesartan; hydrochlorothiazide - tablet - 300mg ; 12.5mg

Irbesartan 300mg Hydrochlorothiazide 12.5mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

irbesartan 300mg hydrochlorothiazide 12.5mg tablets

actavis uk ltd - irbesartan; hydrochlorothiazide - tablet - 300mg ; 12.5mg